Description:
Phase I and Fast Track proposals will be accepted
Direct-to-Phase II proposals will not be accepted
Number of anticipated awards: 4-5
Budget (total costs):
Phase I: $ 300,000 for up to 2 years
Phase II: $ 1 million for up to 3 years
Background
An estimated 1.1 million people in the US are living with HIV, and one in seven are unaware of their infection. As a result,
they are not accessing the care and treatment they need to stay healthy and reduce the likelihood of transmitting the virus to
their partners. A US Government initiative, Ending the HIV Epidemic (https://www.hiv.gov/federal-response/ending-thehiv-epidemic/overview), and the National HIV/AIDS Strategy (https://www.hiv.gov/federal-response/national-hiv-aidsstrategy/national-hiv-aids-strategy-2022-2025#) seeks to reduce the number of new HIV infections in the United States by
90 percent by 2030. Part of this goal includes widespread HIV testing to reduce undiagnosed HIV infection and connect
people to HIV medical care as soon as possible, which will improve the health of people living with HIV and prevent
transmission. The small business innovation program is uniquely suited to reduce HIV incidence in the US because funds
can only be spent domestically and not abroad
